These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34329427)

  • 1. SARS-CoV-2 Antibodies and Associated Factors at Different Hospitalization Time Points in 192 COVID-19 Cases.
    Ou J; Tan M; He H; Tan H; Mai J; Long Y; Jiang X; He Q; Huang Y; Li Y; Chen R; Li L; Shi Y; Li F
    J Appl Lab Med; 2021 Sep; 6(5):1133-1142. PubMed ID: 34329427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of the serum IgM and IgG to SARS-CoV-2 in coronavirus disease-2019.
    Wu LX; Wang H; Gou D; Fu G; Wang J; Guo BQ
    J Clin Lab Anal; 2021 Jan; 35(1):e23649. PubMed ID: 33184940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19.
    Qin X; Shen J; Dai E; Li H; Tang G; Zhang L; Hou X; Lu M; Wu X; Duan S; Zhang J; Tsoi MF; Jiang P; Li Y
    BMC Immunol; 2021 Feb; 22(1):14. PubMed ID: 33596826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
    Al-Mughales JA; Al-Mughales TJ; Saadah OI
    Front Immunol; 2021; 12():705441. PubMed ID: 34539635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of Detection of Anti-SARS-CoV-2 IgG/IgM and SARS-CoV-2 RNA in Respiratory Tract Specimens in 48 COVID-19 Patients.
    Wu E; Zhang X; Zheng Y; Luo Z; Zhai W; Yin Z; Chen D; Wang Z; Zhai J; Han Y; Liu H; Li R; Wang Y; Feng Y; Shi G; Ma Y
    Clin Lab; 2021 Nov; 67(11):. PubMed ID: 34758225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect.
    Maine GN; Lao KM; Krishnan SM; Afolayan-Oloye O; Fatemi S; Kumar S; VanHorn L; Hurand A; Sykes E; Sun Q
    J Clin Virol; 2020 Dec; 133():104663. PubMed ID: 33161369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities.
    Orner EP; Rodgers MA; Hock K; Tang MS; Taylor R; Gardiner M; Olivo A; Fox A; Prostko J; Cloherty G; Farnsworth CW
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115300. PubMed ID: 33388575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
    Zhou C; Bu G; Sun Y; Ren C; Qu M; Gao Y; Zhu Y; Wang L; Sun L; Liu Y
    J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
    Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
    Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients.
    Sun B; Feng Y; Mo X; Zheng P; Wang Q; Li P; Peng P; Liu X; Chen Z; Huang H; Zhang F; Luo W; Niu X; Hu P; Wang L; Peng H; Huang Z; Feng L; Li F; Zhang F; Li F; Zhong N; Chen L
    Emerg Microbes Infect; 2020 Dec; 9(1):940-948. PubMed ID: 32357808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months.
    Zheng Y; Zhang Q; Ali A; Li K; Shao N; Zhou X; Ye Z; Chen X; Cao S; Cui J; Zhou J; Wang D; Hou B; Li M; Cui M; Deng L; Sun X; Zhang Q; Yang Q; Li Y; Wang H; Lei Y; Yu B; Cheng Y; Tong X; Men D; Zhang XE
    Virol Sin; 2021 Oct; 36(5):869-878. PubMed ID: 33661489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological chemiluminescence immunoassay for the diagnosis of SARS-CoV-2 infection.
    Lijia S; Lihong S; Huabin W; Xiaoping X; Xiaodong L; Yixuan Z; Pin H; Yina X; Xiaoyun S; Junqi W
    J Clin Lab Anal; 2020 Oct; 34(10):e23466. PubMed ID: 32671890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies.
    Mairesse A; Favresse J; Eucher C; Elsen M; Tré-Hardy M; Haventith C; Gruson D; Dogné JM; Douxfils J; Göbbels P
    Clin Biochem; 2020 Dec; 86():23-27. PubMed ID: 32858061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
    Hiki M; Tabe Y; Ai T; Matsue Y; Harada N; Sugimoto K; Matsushita Y; Matsushita M; Wakita M; Misawa S; Idei M; Miida T; Tamura N; Takahashi K; Naito T
    PLoS One; 2021; 16(4):e0249449. PubMed ID: 33822809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
    Charpentier C; Ichou H; Damond F; Bouvet E; Chaix ML; Ferré V; Delaugerre C; Mahjoub N; Larrouy L; Le Hingrat Q; Visseaux B; Mackiewicz V; Descamps D; Fidouh-Houhou N
    J Clin Virol; 2020 Nov; 132():104618. PubMed ID: 32919222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors.
    Luo C; Liu M; Li Q; Zheng X; Ai W; Gong F; Fan J; Liu S; Wang X; Luo J
    Int J Infect Dis; 2021 Jul; 108():57-62. PubMed ID: 33932603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
    Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
    Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset.
    Lou B; Li TD; Zheng SF; Su YY; Li ZY; Liu W; Yu F; Ge SX; Zou QD; Yuan Q; Lin S; Hong CM; Yao XY; Zhang XJ; Wu DH; Zhou GL; Hou WH; Li TT; Zhang YL; Zhang SY; Fan J; Zhang J; Xia NS; Chen Y
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32430429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.